Exactis Innovation Selects Ion GeneStudio S5 Systems and Oncomine Assays to Drive Canadian Clinical Trial Studies
Exactis Innovation Selects Ion GeneStudio S5 Systems and Oncomine Assays to Drive Canadian Clinical Trial Studies Laboratory network standardizes on common NGS platform to efficiently profile patient samples across multiple cancer centers CARLSBAD, Calif., March 28, 2018 /PRNewswire/ — At risk cancer patients across Canada may now be able to have their tumors molecularly profiled... Read more